Hyoscine Butylbromide Morningside Healthcare (Hyoscine Butylbromide)

The drug blocks muscarinic (M1‑M3) receptors on smooth‑muscle cells, preventing acetylcholine from triggering contraction. This antagonism reduces calcium influx, leading to muscle relaxation and alleviation of spasm in the gut and biliary system.

The appropriate dose of Hyoscine Butylbromide is determined by the prescribing clinician based on the patient’s condition, age, weight and overall health. Dosage instructions are provided on the prescription label and should be followed exactly.

Safety data for Hyoscine Butylbromide in pregnancy or lactation are limited. Healthcare providers should evaluate the risk‑benefit profile before prescribing to pregnant or nursing women, and use only if clearly needed.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Hyoscine Butylbromide is a peripheral anticholinergic that does not cross the blood‑brain barrier, offering targeted smooth‑muscle relaxation with fewer central nervous system effects compared with some other antispasmodics like dicyclomine. Its rapid onset makes it useful for acute spasm relief.

Store the product at ambient temperature below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Hyoscine Butylbromide is taken orally, typically as a tablet or capsule, with or without food as directed by the prescriber. Swallow the dosage form whole with a glass of water; do not crush or chew unless specifically instructed.

Serious risks include severe allergic reactions (e.g., anaphylaxis), paralytic ileus, marked hypotension, and rare skin disorders such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms like swelling, difficulty breathing, severe abdominal pain or rash.

Hyoscine Butylbromide should be avoided in individuals with known hypersensitivity to the drug, in patients with narrow‑angle glaucoma, severe urinary retention, or myasthenia gravis, and in anyone for whom anticholinergic therapy is contraindicated.